ホーム
Fermion Oy logo
Fermion Oy

会社概要

  • 正式社名: Fermion Oy
  • 登録国: Finland
  • 住所: Koivu-Mankkaan tie 6 A, FI-02200 Espoo
  • 従業員数: 250 - 499
説明:

Fermion, a wholly owned subsidiary of Orion Corporation and headquartered in Espoo, Finland, is a fully integrated CDMO offering API and formulation services. Its API portfolio includes over 30 generic APIs and more than 10 NCEs, with two manufacturing sites and R&D facilities in Finland. Fermion has expanded capabilities in HPAPI production. Drug product CMO services cover hormonal and non-hormonal semi-solids, cytotoxic oral solids, and packaging, supported by three manufacturing sites and one packaging center under Orion. Note: Product(s) under patent(s) are offered only for R&D purposes as per the Patent Act & not for commercial sale.

事業活動

受託・アウトソーシングサービス

製造業者サービスプロバイダー受託製造業者(CMO)原薬メーカー

先発品原薬

製造業者受託製造業者(CMO)原薬メーカー

薬事・市場調査サービス

サービスプロバイダー

試験・分析サービス

サービスプロバイダー

当社の製品・サービス

Sell · Active Pharmaceutical Ingredients (APIs)
Nintedanib Esylate - Fermion Oy
Sell · Active Pharmaceutical Ingredients (APIs)
Alprazolam - Fermion Oy
Sell · Active Pharmaceutical Ingredients (APIs)
Mercaptopurine - Fermion Oy
Sell · Active Pharmaceutical Ingredients (APIs)
Budesonide - Fermion Oy
Sell · Active Pharmaceutical Ingredients (APIs)
Methotrexate - Fermion Oy
Sell · Active Pharmaceutical Ingredients (APIs)
Carbidopa - Fermion Oy
Sell · Active Pharmaceutical Ingredients (APIs)
Nadolol - Fermion Oy
Sell · Active Pharmaceutical Ingredients (APIs)
Entacapone - Fermion Oy
Sell · Active Pharmaceutical Ingredients (APIs)
Toremifene Citrate - Fermion Oy
Sell · Active Pharmaceutical Ingredients (APIs)
Levosimendan - Fermion Oy
Sell · Active Pharmaceutical Ingredients (APIs)
Tolnaftate - Fermion Oy

認証

CEP証明書

FDA

DMF

GMP

証明

CPHI Americas 2026
CPHI Americas 2026
06/2026 – 06/2026

CPHI Americas 2026

場所
Pennsylvania Convention Center, Philadelphia
フィルター:
並べ替え:

    コメントはありません。